Demographic Variance in COVID‐19 Vaccine Hesitancy Among Reproductive‐Aged Females During the First Year of the Vaccine Rollout

ABSTRACT Objective Initial COVID‐19 vaccine trials excluded pregnant individuals, making eventual vaccine recommendations nongeneralizable. After noninferiority was established, the CDC, WHO, and ACOG supported vaccination of this group. However, only 31% of pregnant people accepted vaccination. This study aims to assess COVID‐19 vaccine hesitancy in a diverse cohort of reproductive‐aged females. Methods We used a validated WHO vaccine hesitancy survey tool, modified to address the COVID‐19 vaccine specifically. From August to November 2021, people capable of pregnancy aged 18–50 years were recruited from inpatient and outpatient OB/GYN services at a large, urban, academic centre in the Midwestern United States. The responses were collected anonymously and analysed using Kruskal–Wallis H and Mann–Whitney U tests. Results Fifty‐one of sixty participants partially or fully completed the survey. Black individuals were more vaccine‐hesitant in general than Hispanic and White individuals ( H [2] = 11.179, p < 0.01), and they were more hesitant toward the COVID‐19 vaccine specifically ( H [2] = 9.396, p < 0.01). Pregnant people were less confident that the COVID‐19 vaccine was safe overall ( H [2] = 11.473, p < 0.005) compared to those recently pregnant or not pregnant. Individuals not using contraception reported being significantly less confident in the safety of the COVID‐19 vaccine ( U = 96.500, p < 0.05). Individuals who declined the flu vaccine were more likely to be COVID‐19 vaccine‐hesitant ( U = 79.500, p < 0.001). Participants' age and occupation were not associated with vaccine hesitancy. Conclusion Vaccine hesitancy particularly among some demographic groups highlights the need to study the underlying factors contributing to a lack of confidence in the safety of the COVID‐19 vaccine. Synopsis Our validated survey‐based study found that Black participants capable of pregnancy were the most vaccine‐hesitant, highlighting a missed opportunity to care for these individuals.

Authors

Institutions

Publication Details

Journal
Reproductive Female and Child Health
Published
2024-10-21
DOI
https://doi.org/10.1002/rfc2.70003
Primary Topic
COVID-19 Impact on Reproduction
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Demographic Variance in COVID‐19 Vaccine Hesitancy Among Reproductive‐Aged Females During the First Year of the Vaccine Rollout

Monika Stoskute, Quetzal A. Class, Nabiha Shamshuddin, Leah C. Butler et al.
Reproductive Female and Child Health
COVID-19 Impact on Reproduction
article

Demographic Variance in COVID‐19 Vaccine Hesitancy Among Reproductive‐Aged Females During the First Year of the Vaccine Rollout

Monika Stoskute, Quetzal A. Class, Nabiha Shamshuddin, Leah C. Butler, C Barry, Valentina Orlando, Amitha Ganti, Samie Gilani
article en

Abstract

ABSTRACT Objective Initial COVID‐19 vaccine trials excluded pregnant individuals, making eventual vaccine recommendations nongeneralizable. After noninferiority was established, the CDC, WHO, and ACOG supported vaccination of this group. However, only 31% of pregnant people accepted vaccination. This study aims to assess COVID‐19 vaccine hesitancy in a diverse cohort of reproductive‐aged females. Methods We used a validated WHO vaccine hesitancy survey tool, modified to address the COVID‐19 vaccine specifically. From August to November 2021, people capable of pregnancy aged 18–50 years were recruited from inpatient and outpatient OB/GYN services at a large, urban, academic centre in the Midwestern United States. The responses were collected anonymously and analysed using Kruskal–Wallis H and Mann–Whitney U tests. Results Fifty‐one of sixty participants partially or fully completed the survey. Black individuals were more vaccine‐hesitant in general than Hispanic and White individuals ( H [2] = 11.179, p < 0.01), and they were more hesitant toward the COVID‐19 vaccine specifically ( H [2] = 9.396, p < 0.01). Pregnant people were less confident that the COVID‐19 vaccine was safe overall ( H [2] = 11.473, p < 0.005) compared to those recently pregnant or not pregnant. Individuals not using contraception reported being significantly less confident in the safety of the COVID‐19 vaccine ( U = 96.500, p < 0.05). Individuals who declined the flu vaccine were more likely to be COVID‐19 vaccine‐hesitant ( U = 79.500, p < 0.001). Participants' age and occupation were not associated with vaccine hesitancy. Conclusion Vaccine hesitancy particularly among some demographic groups highlights the need to study the underlying factors contributing to a lack of confidence in the safety of the COVID‐19 vaccine. Synopsis Our validated survey‐based study found that Black participants capable of pregnancy were the most vaccine‐hesitant, highlighting a missed opportunity to care for these individuals.

Reproductive Female and Child HealthVol. 3(4)
Baylor College of Medicine (US), University of Illinois Chicago (US), Advocate Illinois Masonic Medical Center (US), Saint Louis University (US)
Good health and well-being
Openalex Percentile: Top 70%
COVID-19 Impact on Reproduction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.